Infective Endocarditis Prevalence 26 Percent in Patients With E. faecalis
MONDAY, July 8, 2019 -- The prevalence of infective endocarditis (IE) is about 26 percent among patients with Enterococcus faecalis bacteremia, according to a study published in the July 16 issue of the Journal of the American College of Cardiology.
Anders Dahl, M.D., Ph.D., from Herlev Gentofte University Hospital in Copenhagen, Denmark, and colleagues examined the prevalence of IE in patients with E. faecalis bacteremia in a prospective multicenter study conducted in consecutive patients from Jan. 1, 2014, to Dec. 31, 2016. Data were included for 344 patients with E. faecalis bacteremia who were examined using echocardiography; 74 percent of the cases had transesophageal echocardiography (TEE).
The researchers found that definite endocarditis was diagnosed in 90 patients, yielding a prevalence of 26.1 ± 4.6 percent. Prosthetic heart valve, community acquisition, three or more positive blood culture bottles, unknown portal of entry, monomicrobial bacteremia, and immunosuppression were risk factors for IE (odds ratios, 3.93, 3.35, 3.69, 2.36, 2.73, and 2.82, respectively).
"On the basis of our findings, we recommend increasing the use of echocardiography in E. faecalis bacteremia," the authors write. "We find an endocarditis prevalence of 26 percent and propose that TEE should be considered in all patients with E. faecalis bacteremia, especially those with relevant risk factors."
© 2020 HealthDay. All rights reserved.
Posted: July 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.